Patents Represented by Attorney John J. Kolano
  • Patent number: 5374632
    Abstract: 2,3-Dihydro-1-(8-methyl-1,2,4-triazolo [4,3-b]pyridazin-6-yl)-4(1H)-pyridinone has been prepared in substantially pure form and has been found to be useful for alleviating bronchial spasms in mammals. Synthesis of this material through phenylselenyl intermediates is described.
    Type: Grant
    Filed: August 17, 1992
    Date of Patent: December 20, 1994
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: Robert J. Cregge
  • Patent number: 5227479
    Abstract: The present invention relates to an efficient new route for the preparation of (+)-nojirimycin and (+)-1-deoxynojirimycin which involves the stereoselective reductive amination of 1,2-O-isopropylidene-5-oxo-.alpha.-D-glucuronolactone. The reductive amination uses particular oximes of the 5-oxo compound.
    Type: Grant
    Filed: November 14, 1990
    Date of Patent: July 13, 1993
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Peter B. Anzeveno, Laura J. Creemer
  • Patent number: 5218110
    Abstract: The present invention relates to 4-azido-.DELTA..sup.4 -steroids which are useful as inhibitors of 5.alpha.-reductase. The compounds are prepared by the reaction of an appropriate 4-azido steroid with triphenylphosphine in an aqueous inert solvent with heating.
    Type: Grant
    Filed: March 20, 1992
    Date of Patent: June 8, 1993
    Assignee: Merrell Dow Pharmaceuticals
    Inventor: Philip M. Weintraub
  • Patent number: 5194424
    Abstract: C.sup.63 -Amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin wherein the amide moiety is derived from a di- or poly-amine. The derivatives are prepared by reacting 34-de(acetylglucosaminyl)- 34-deoxy-teicoplanins with an active esters forming reagent such as chloroacetonitrile and then contacting the resulting active esters with the appropriate di- or poly-amine. The amide derivatives which are active against Gram-positive microorganisms, in particular against Group A Streptococci were found to be active also against bacteria which are resistant to glycopeptide antibiotics.
    Type: Grant
    Filed: May 20, 1992
    Date of Patent: March 16, 1993
    Assignee: Gruppo Lepetit SpA
    Inventors: Adriano Malabarba, Jurgen K. Kettenring
  • Patent number: 5189032
    Abstract: The present invention relates to 4-amino-.DELTA..sup.4,6 -steroids which are useful as inhibitors of 5.alpha.-reductase. The compounds are prepared by the reaction of an appropriate 4,5-epoxy steroid with sodium azide in an inert solvent in the presence of a strong acid such as sulfuric acid at about 100.degree. C.
    Type: Grant
    Filed: March 20, 1992
    Date of Patent: February 23, 1993
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: Philip M. Weintraub
  • Patent number: 5189052
    Abstract: Imidazole-2-thione derivatives useful as antihypertensive agents are described herein. The compounds are obtained by cyclization of an appropriate open-chain compound such as an appropriately substituted thiourea.
    Type: Grant
    Filed: December 20, 1989
    Date of Patent: February 23, 1993
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Donald P. Matthews, James R. McCarthy, Jeffrey P. Whitten, Robert J. Broersma, Jr.
  • Patent number: 5185320
    Abstract: The present invention is directed to a new class of teicoiplanin derivatives, a process for preparing them and their use as pharmaceutically active substances.
    Type: Grant
    Filed: May 22, 1991
    Date of Patent: February 9, 1993
    Assignee: Gruppo Lepetit S.p.A.
    Inventors: Aldo Trani, Pierfausto Seneci, Pietro Ferrari, Romeo Ciabatti
  • Patent number: 5166201
    Abstract: The present invention is directed to a group of androstane compounds which contain an ethylene radical bridging the 2- and 19-positions. These compounds are useful as aromatase inhibitors and they are prepared by the cyclization of a 19-[2-(4-toluenesulfonyloxy)ethyl]androst-4-ene-3,17-dione using a strong base.
    Type: Grant
    Filed: November 30, 1990
    Date of Patent: November 24, 1992
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: J. O'Neal Johnston, Norton P. Peet, Joseph P. Burkhart
  • Patent number: 5147863
    Abstract: This invention relates to novel derivatives of 2,2'-bi-1H-imidazoles, to the processes and intermediates used in their preparation, to their ability to exert the pharmacologic effects of lowering high blood pressure and of increasing heart contractile force and to their use as chemotherpauetic agents useful in treating cardiac insufficiency and hypertension.
    Type: Grant
    Filed: October 17, 1990
    Date of Patent: September 15, 1992
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Donald P. Matthews, Jeffrey P. Whitten, James R. McCarthy
  • Patent number: 5143909
    Abstract: The present invention relates to a method for the inhibition of C.sub.17-20 lyase enzyme which comprises administering to a patient in need of such inhibition, an effective amount of certain 4-amino-17-(hydroxyalkyl or dihydroxyalkyl)steroids or their esters or ethers. Certain of the aminosteroids used in the process are novel compounds.
    Type: Grant
    Filed: March 19, 1991
    Date of Patent: September 1, 1992
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Philip M. Weintraub, Cynthia A. Gates, Thomas R. Blohm
  • Patent number: 5132286
    Abstract: The present invention is directed to the essentially pure preparation of an antibiotic substance arbitrarily designated antibiotic L 17054. This antibiotic substance is obtained from the known antibiotic substance named teicoplanin (formerly teichomycin) by chemical treatment. The new compound and the pharmaceutically acceptable salts possess antimicrobial activity.
    Type: Grant
    Filed: May 17, 1991
    Date of Patent: July 21, 1992
    Assignee: Gruppo Lepetit S.p.A.
    Inventors: Adriano Malabarba, Angelo Borghi, Paolo Strazzolini, Bruno Cavalleri, Carolina Coronelli
  • Patent number: 5130424
    Abstract: The present invention relates to 4-amino-.DELTA..sup.4,6 -steroids which are useful as inhibitors of 5.alpha.-reductase. The compounds are prepared by the reaction of an appropriate 4,5-epoxy steroid with sodium azide in an inert solvent in the presence of a strong acid such as sulfuric acid at about 100.degree. C.
    Type: Grant
    Filed: July 2, 1991
    Date of Patent: July 14, 1992
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: Philip M. Weintraub
  • Patent number: 5126488
    Abstract: The present invention is directed to 2.beta.,19-(methyleneamino)androst-4-ene-3,17-dione which has the formula ##STR1## and the corresponding 17.beta.-ol which are useful as aromatase inhibitors. The compounds are prepared by the cyclization of an appropriate 19-[N-protected-[(2-methoxyethoxy)methylamino] steroid using titanium tetrachloride followed by, if desired, selective reduction of the 17-ketone.
    Type: Grant
    Filed: November 30, 1990
    Date of Patent: June 30, 1992
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: J. O'Neal Johnston, Joseph P. Burkhart, Norton P. Peet
  • Patent number: 5120840
    Abstract: The present invention relates to 4-amino-.DELTA..sup.4 -steroids which are useful as inhibitors of 5.alpha.-reductase. The compounds are prepared by the reaction of an appropriate 4-azido steroid with triphenylphosphine in an aqueous inert solvent with heating.The present application is a continuation-in-part of application Ser. No. 561,041, filed Aug. 1, 1990 and application Ser. No. 671,555, filed Mar. 19, 1991.
    Type: Grant
    Filed: July 2, 1991
    Date of Patent: June 9, 1992
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Philip M. Weintraub, Joseph P. Burkhart, Thomas R. Blohm
  • Patent number: 5099037
    Abstract: The present invention is directed to a group of compounds which are 2,19-methylenoxy or 2,19-methylenethio bridged steroids, and related steroidal compounds. These compounds are useful as aromatase and 19-hydroxylase inhibitors.
    Type: Grant
    Filed: March 25, 1991
    Date of Patent: March 24, 1992
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Norton P. Peet, J. O'Neal Johnston, Joseph P. Burkhart
  • Patent number: 5093501
    Abstract: Castanospermine is prepared by starting from 5-(t-BOC)amino-5-deoxy-1,2-O-isopropylidene-.alpha.-D-glucuronolactone. Two additional carbons are added to the starting material using ethyl acetate and a strong base and the resulting cyclic hemiketal is subjected to a series of reductions, with intervening removal of protecting groups, to give the castanospermine. A substituted hydroxypyrrolidinone and a substituted hydroxypyrrolidine serve as intermediates in the process.
    Type: Grant
    Filed: June 10, 1991
    Date of Patent: March 3, 1992
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Peter B. Anzeveno, Paul T. Angell, Laura J. Creemer
  • Patent number: 5079254
    Abstract: Amide and ester derivatives of 6-amino-octahydro-1,7,8-indolizinetriol are described herein. The compounds are prepared from castanospermine by replacing the appropriate hydroxy function with an amino function while protecting the other hydroxy groups in the meantime. The compounds are useful as hexosaminidase inhibitors.
    Type: Grant
    Filed: June 4, 1990
    Date of Patent: January 7, 1992
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Paul S. Liu, Mohinder S. Kang
  • Patent number: 5075464
    Abstract: This invention is directed to 17.beta.-(cyclopropylamino)androstenes and also to a method for using such compounds in the treatment of androgen-dependent disorders. The compounds are prepared by the hydride reduction of an appropriate steroidal imine or enamine.
    Type: Grant
    Filed: June 14, 1989
    Date of Patent: December 24, 1991
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Thomas R. Blohm, Michael R. Angelastro
  • Patent number: 5066807
    Abstract: Castanospermine is prepared by starting from 5-(t-BOC)amino-5-deoxy-1,2-O-isopropylidene-.alpha.-D-glucuronolactone. Two additional carbons are added to the starting material using ethyl acetate and a strong base and the resulting cyclic hemiketal is subjected to a series of reductions, with intervening removal of protecting groups, to give the castanospermine. A substituted hydroxypyrrolidinone and a substituted hydroxypyrrolidine serve as intermediates in the process.
    Type: Grant
    Filed: March 12, 1990
    Date of Patent: November 19, 1991
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Peter B. Anzeveno, Paul T. Angell, Laura J. Creemer
  • Patent number: 5057613
    Abstract: Imidazole-2-thione derivatives useful as antihypertensive agents are described herein. The compounds are obtained by cyclization of an appropriate open-chain compound such as an appropriately substituted thiourea.
    Type: Grant
    Filed: October 27, 1987
    Date of Patent: October 15, 1991
    Assignee: Merrell Dow Pharmaceuticals
    Inventors: Donald P. Matthews, James R. McCarthy, Jeffrey P. Whitten, Robert J. Broersma, Jr.